DecisionMap Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
4,364
-456
-9% -$106K 0.62% 41
2026
Q1
$1.18M Sell
4,820
-308
-6% -$71.7K 0.76% 31
2025
Q4
$1.06M Buy
5,128
+33
+0.6% +$6.53K 0.65% 42
2025
Q3
$945K Sell
5,095
-525
-9% -$89.9K 0.61% 47
2025
Q2
$858K Sell
5,620
-198
-3% -$30.4K 0.59% 46
2025
Q1
$965K Buy
5,818
+488
+9% +$76.4K 0.73% 37
2024
Q4
$771K Buy
+5,330
New +$826K 0.61% 48

Other funds holding JNJ

DecisionMap Wealth Management's JNJ Position: Q2 2026 in Review

DecisionMap Wealth Management reduced its Johnson & Johnson (JNJ) stake by 9.5% in Q2 2026, selling an estimated $106K and leaving 4,364 shares worth $1.11M. The position accounts for 0.62% of the portfolio, ranked #41.

DecisionMap Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.18M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • DecisionMap Wealth Management held 4,364 shares of Johnson & Johnson worth $1.11M as of Q2 2026.
  • DecisionMap Wealth Management sold 456 Johnson & Johnson shares in Q2 2026, an estimated $106K.
  • Johnson & Johnson made up 0.62% of DecisionMap Wealth Management's portfolio in Q2 2026, its #41 holding.
  • DecisionMap Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • DecisionMap Wealth Management's Johnson & Johnson position peaked at $1.18M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on DecisionMap Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.